In the Pipeline's Derek Lowe takes a look at chemical biology, and says that the combination of organic chemistry and molecular biology is "one of the most interesting and productive research frontiers." While biologists have been looking at genes and their proteins, mutating and manipulating them in living systems, chemists have been working with enzymes as a way of controlling molecules.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.